Hebei Xinanran Biotechnology Co., Ltd. is a large-scale modern and high-tech enterprise group dedicated to the research and development, production and sales of animal drugs. Since 2004, it has been engaged in the production of veterinary drugs for nearly 20 years, and its flagship product, “Glandular Stomach Quick Treatment”, has already become a well-known “explosive product” in the industry. On this basis, “Xin Anran” seizes the opportunity, forge ahead, build a new pattern, help new development, and achieve a new leap. On the basis of existing poultry products, the company will successfully develop livestock products by the end of 2021 to achieve business expansion. Further highlight the main business, improve the specialty, focus on emerging fields, consolidate the strategic market, increase the market increment, and fully integrate into the broader development space.
In order to enable business personnel to have a better understanding of the company and its products, on June 14, the company held the “Hebei Xinanran Animal Medicine Division 2022 Observation Meeting”.
At the meeting, President Hu Yingjie said that my country is a big country in animal husbandry, with a huge number of economic animals breeding groups. The output of meat, poultry and eggs has ranked first in the world for many years, and the demand for veterinary drugs is also relatively strong. In order to better create high-quality veterinary drugs, the company’s hardware facilities have been updated and iterated. It has successively invested more than 20 million yuan to introduce first-class production equipment and laboratory testing equipment at home and abroad to escort product quality. President Hu Yingjie also said that although we have passed the acceptance of the new version of veterinary drug GMP, we got the “ticket” to enter the new era early. But this is only the beginning of competition. Veterinary drug companies must continue to invest heavily in innovation system and supply chain construction to form a differentiated competitive advantage in order to become bigger and stronger. The development of the company is inseparable from everyone’s efforts. I hope everyone can strengthen their confidence, bring our livestock products to the market, and jointly establish a three-dimensional network model with poultry products to cover the whole situation.
Wang Yongshan, general manager of the animal medicine business department, introduced that the company currently has three major sectors: poultry medicine, animal medicine, and foreign trade. In the years of hard work of the business department, it has built sales covering Northeast China, North China, East China, South China, Southwest China and other places. Network and professional service system. In 2020, the flagship product Gastroenterotherapy will achieve sales revenue of more than 30 million yuan, becoming a famous brand product in the industry for the treatment of infectious adenomyosis. The foreign trade market has also expanded to Africa and Southeast Asia, and a sales pattern with domestic trade as the mainstay and foreign trade as the supplement has now been formed.
Hebei Xinanran Biotechnology Co., Ltd. has 10 production lines and 14 dosage forms, covering veterinary drugs, traditional Chinese medicines and additives. Hu Jianjun, director of the R&D department, emphasized that technological innovation determines the future pace of an enterprise. School-enterprise cooperation has become an important part of enterprise development strategy. At present, the company maintains close scientific research cooperation with colleges and universities such as China Agricultural University, Huazhong Agricultural University, Yangzhou University and Hebei Agricultural University, transforming scientific and technological achievements into product applications and bringing them to the market. Farmers benefit, the company can develop better.
In order to make everyone understand the company more intuitively and understand the product production process, Bai Lishan, director of the quality inspection department and the production department, led everyone into the door of “home” to experience Xin’anran’s intelligent and modern atmosphere, broaden their horizons, and enhance their understanding of Xin’anran’s culture, Intelligent manufacturing, understanding of product quality, and more accurate and comprehensive dissemination of Xinanran brand.
Through this meeting, Wu Zhenjia, general manager of Tangshan Kaiping District Niudun Animal Husbandry Co., Ltd. and Xin’anran Animal Medicine Division Hebei Branch, and his team members had a deeper understanding of the company and a clearer grasp of development ideas. , have firm confidence in the development prospects. As grassroots sales, they will maintain a down-to-earth and positive attitude, overcome difficulties, move forward bravely, and strive to create a new situation of high-quality development of sales business.
Post time: Sep-30-2022